For Research Use Only. Not for use in diagnostic procedures. Others KAPA HyperCap Oncology panel RUO KAPA HyperCap Oncology panel SEQ-KAPA-0263 09 462 457 001 9 462 457 001 09462457001 9462457001 09462457001 KAPA HyperCap Oncology panel 24 rxn KAPA HyperCap Oncology panel 07613336188378 Reagents, kits 24 reactions Not Available 09 462 384 001 9 462 384 001 09462384001 9462384001 09462384001 KAPA HyperCap Oncology panel 12 rxn KAPA HyperCap Oncology panel 07613336188361 Reagents, kits 12 reactions Not Available 09 462 465 001 9 462 465 001 09462465001 9462465001 09462465001 KAPA HyperCap Oncology panel 48 rxn KAPA HyperCap Oncology panel 07613336188385 Reagents, kits 48 reactions Not Available The KAPA HyperCap Oncology panel is a 214 Kb capture target panel covering the full coding sequence of 13 genes related to somatic oncology research (ATM, BRCA1, BRCA2, BRIP1, CHEK2, EGFR, ERBB2, KRAS, MET, MYCN, RAD51C, RAD51D, TP53) as well as hotspot variants across 69 relevant genes, which are found in commercially available controls. It is readily available from stock and it offers consistent quality by NGS probes QC of every lot. It is optimized to deliver high uniformity and high specificity from FFPET and cfDNA samples. KAPA HyperCap Target Enrichment Probes are stable at -15°C to -25°C until the expiration date printed on the label, lyophilized or resuspended. en

User profile

Select your user profile

KAPA HyperCap Oncology panel

Overview

Ordering information

Technical documents

Compatible products

Contact us